Search tips
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
16 April 2019 - L0010
Favorable Response to Oral Ibrexafungerp (formerly SCY-078) in Patients with Refractory Fungal Diseases, Interim Analysis by Pathogen from a Phase 3 Open-label Study (FURI)
Oliver A Cornely, Oliver A. Cornely, Luis Ostrosky-Zeichner, Rachel Miller, Andrej Spec, George Thompson, Thomas J. Walsh, Riina Richardson, Robert Krause, Peter G. Pappas, Kathleen Mullane, Caryn G. Morse, John W. Sanders, Günter Weiss, Oliver Witzke, Jose Vazquez, Marisa H. Miceli, Thomas Patterson, Martin Hoenigl, Barbara Alexander, David Angulo Gonzalez
16 April 2019 - L0011
Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of the Monoclonal Antibody Combination ASN100 for the Prevention of Staphylococcus aureus Pneumonia in Endotracheal Heavily Colo
Zoltan Magyarics, Karin Provost, Nimrod Adi, Tomasz Czarnik, Khatuna Japaridze, Nikoloz Kartsivadze, Mikhail Kirov, Ed Campanaro, Matthew Goodwin, Lori Muir, Marin Kollef, Chris Stevens
16 April 2019 - L0012
Exebacase (Lysin CF-301) improved clinical responder rates in methicillin resistant Staphylococcus aureus bacteremia including endocarditis compared to standard of care antibiotics alone in a first-in patient Phase 2 study
Vance G. Fowler, Anita Das, Joy Lipka, Raymond Schuch, Cara Cassino
16 April 2019 - L0014
Combination antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia: the CAMERA2 randomised controlled trial
Steven Y. C. Tong, Joshua Saul Davis, Hong Foo, David Lye, Jane Nelson, Matthew O'Sullivan, David L. Paterson, Mical Paul, Archana Sud, Dafna Yahav
16 April 2019 - L0013
Efficacy and Safety Profile of Suvratoxumab, a Novel Anti-Staphylococcus aureus Monoclonal Antibody: Results of the SAATELLITE Study in Mechanically Ventilated Intensive Care Unit Patients
Bruno François, Miguel Garcia Sanchez, Philippe Eggimann, Pierre-Francois Dequin, Pierre-Francois Laterre, Vincent Huberlant, Dolores Escudero, Thierry Boulain, Cédric Bretonnière, Jerome Pugin, José Trenado Álvarez, Ana Catalina Padilla, S. Omar Ali, Kathryn Shoemaker, Alexey Ruzin, Vadryn Pierre, Yuling Wu, Julie VIGNAUD, Susan Colbert, Terramika Bellamy, Filip Dubovsky, Hasan S. Jafri
16 April 2019 - 389791
Exebacase (Lysin CF-301) improved clinical responder rates in methicillin-resistant Staphylococcus aureus bacteraemia including endocarditis compared to standard of care antibiotics alone in a first-in patient Phase 2 study
Vance G. Fowler
16 April 2019 - 389792
Efficacy and Safety Profile of Suvratoxumab, a Novel Anti-Staphylococcus aureus Monoclonal Antibody: Results of the SAATELLITE Study in Mechanically Ventilated Intensive Care Unit Patients
Bruno Francois
22 April 2017 - OS0250B
SYN-004 (ribaxamase) Significantly Reduced the Incidence of Clostridium difficile Infection in a Phase 2b Clinical Study
John Kokai-Kun, Tracey Roberts, Olivia Coughlin, Heidi Whalen, Charles Le, Klaus Gottlieb, Joseph Sliman
22 April 2017 - OS0250I
Empirical antimicrobial therapy withdrawal after 72 hours of apyrexia in hematological patients with febrile neutropenia is safe and reduce unnecessary antibiotic exposure: final results of randomized clinical trial How Long.
Manuela Aguilar-Guisado, Ildefonso Espigado, Almudena Martín-Peña, Carlota Gudiol, José Falantes, Lourdes Vázquez, María Isabel Montero, María de la Luz Martino, Rocío Parody, José González, Sebastián Garzón, Cristina Calderón, Pere Barba, Nancy Rodríguez, José Antonio Pérez Simón, Jose Miguel Cisneros Herreros
22 April 2017 - OS0250C
An analysis of results from the first placebo-controlled trial of single-dose SER-109, an investigational oral microbiome therapeutic to reduce the recurrence of Clostridium difficile infection (CDI)
Michele Trucksis, Ian Baird, Oliver A. Cornely, Yoav Golan, Gail Hecht, Darrell S Pardi, John Pullman, Christopher Polage, Mark H. Wilcox, Patricia Bernardo, Christopher Ford, Edward O'Brien, Rosanne Vetro, Jennifer Wortman, James Weston, Matthew R. Henn
22 April 2017 - OS0250H
The OVIVA Trial: Oral versus intravenous antibiotics in the management of bone and joint infection -  a multicentre open label randomised  non-inferiority study. 
Matthew Scarborough, Li Ho Kwong, Ines Rombach, Rhea Zambellas, Benjamin A. Lipsky, Harriet Hughes, Deepa Bose, Simon Warren, Jonathan Folb, Elinor Moore, Neil Jenkins, Susan Hopkins, Andrew Seaton, Carolyn Hemsley, Jonathan Sandoe, Nicola McMeekin, Martin McNally, Sarah Walker, Guy Thwaites, Philip Bejon
22 April 2017 - OS0250D
Cefiderocol Compared with Imipenem/Cirastatin in the Treatment of Adults with Complicated Urinary Tract Infections with or without Pyelonephritis or Acute Uncomplicated Pyelonephritis: Results from a Multicenter, Double-blind, Randomized Study
Mari Ariyasu, Simon Portsmouth, David van Veenhuyzen, Roger Echols, Mitsuaki Machida, Juan Camilo Arjona Ferreira, Tsutae Nagata
22 April 2017 - OS0250G
Adjunctive Rifampicin to Reduce Early mortality from Staphylococcus aureus bacteraemia: final results from the multi-centre, randomised blinded placebo-controlled ARREST trial
Ann Sarah Walker, Guy Thwaites, Matthew Scarborough, Alex Szubert, Emmanuel Nsutebu, Robert Tilley, Julia Greig, Sarah Wyllie, Peter Wilson, Cressida Auckland, Janet Cairns, Pankaj Lal, Timothy Planche, Jane Minton, Fleur Hudson, Susan Hopkins, John Williams, M. Estee Torok, Martin Llewelyn, Jonathan Edgeworth
22 April 2017 - OS0250E
Plazomicin versus Meropenem for the Treatment of Complicated Urinary Tract infection (cUTI) and Acute Pyelonephritis (AP): Results of the EPIC Study
Hina Patel, Daniel Cloutier, Loren Miller, Allison Komirenko, Deborah Cebrik, Kevin Krause, Tiffany Keepers, Lynn Connolly, Florian Wagenlehner
22 April 2017 - OS0250F
Plazomicin (PLZ) Associated with Improved Survival and Safety Comapred to Colistin (CST) in Serious Carbapenem-Resistant Enterobacteriaceae (CRE) Infections: Results of the CARE Study
Hina Patel, Lynn Connolly, Adrian Jubb, Bridget O'Keeffe, Alisa Serio, Alex Smith, Jonathon Gall, Valerie Riddle, Kevin Krause, James McKinnell, Epaminondas Zakynthinos, George L. Daikos
22 April 2017 - OS0250A
A phase II randomized double-blind placebo-controlled trial of ganciclovir to prevent cytomegalovirus (CMV) reactivation in acute critical illness ["GRAIL"]
Ajit P. Limaye, Ajit Limaye, Renee Stapleton, Scott Gunn, James O'Brien, Loiuse Kimball, Lili Peng, D. Clark Files, Peter Morris, Stephen Frankel, Mark Mikkelsen, Duncan Hite, Kyle Enfield, Ying Chen, Gordon Rubenfeld, Michael Boeckh, Matthew Exline, Jay Steingrub, Robert Hyzy
Loading ...
FAQ
To access content in the eLibrary you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.